Page last updated: 2024-10-25

ciprofloxacin and Genetic Diseases, Inborn

ciprofloxacin has been researched along with Genetic Diseases, Inborn in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Genetic Diseases, Inborn: Diseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent's genome or they may be acquired in utero.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Styler, MJ1
Crilley, P1
Biggs, J1
Moul, J1
Copelan, E1
Topolsky, D1
Avalos, B1
Penza, S1
Sabol, P1
Downs, K1
Szer, J1
Brodsky, I1
Marks, DI1

Other Studies

1 other study available for ciprofloxacin and Genetic Diseases, Inborn

ArticleYear
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
    Bone marrow transplantation, 1996, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Marrow Transplantation; Busulfan; Child; Child,

1996